Topic Hub
25 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 25 of 25 clinical reviews.
A clinical breakdown of FDA warnings on compounded semaglutide and tirzepatide, including safety risks, compounding pharmacy standards, and what patients should know before using non-FDA-approved GLP-1 formulations.
Read clinical reviewA strict diet is not required on Ozempic, but specific eating patterns improve weight loss and reduce side effects. Learn what to eat, what to avoid, and how to structure meals while taking semaglutide.
Read clinical reviewFind out whether Aetna covers liraglutide (Saxenda) for weight loss, including prior authorization requirements, step therapy rules, cost-sharing details, and appeal strategies.
Read clinical reviewFind out whether Aetna covers Trulicity (dulaglutide), including formulary tier placement, prior authorization requirements, copay ranges, and alternative GLP-1 options under Aetna plans.
Read clinical reviewFind out whether Affinity Health Plan covers Ozempic (semaglutide), what happened after the Molina Healthcare acquisition, and how to get GLP-1 coverage through New York Medicaid managed care.
Read clinical reviewFind out whether Amerigroup covers Trulicity (dulaglutide), what prior authorization steps apply, expected copays, and alternative GLP-1 options if coverage is denied.
Read clinical reviewFind out whether Blue Cross Blue Shield of Alabama covers Trulicity (dulaglutide), what formulary tier it falls on, prior authorization requirements, and how to reduce your out-of-pocket cost.
Read clinical reviewFind out whether Blue Cross Blue Shield of Illinois covers Saxenda (liraglutide 3.0 mg) for weight loss, including prior authorization requirements, step therapy rules, and alternatives if coverage is denied.
Read clinical reviewFind out whether Blue Cross Blue Shield of Illinois covers Wegovy (semaglutide 2.4 mg) for weight loss, what prior authorization criteria apply, and how to improve your chances of approval.
Read clinical reviewFind out whether Blue Cross Blue Shield of Massachusetts covers liraglutide (Saxenda) for weight loss, including prior authorization requirements, step therapy, copay estimates, and appeal options.
Read clinical reviewFind out whether Blue Cross Blue Shield of Michigan covers Ozempic (semaglutide), what prior authorization criteria apply, expected copays, and how to appeal a denial.
Read clinical reviewFind out whether Blue Cross Blue Shield of Michigan covers Trulicity (dulaglutide) for type 2 diabetes and weight management, including formulary tier, prior authorization requirements, copay estimates, and alternatives.
Read clinical reviewFind out if Blue Cross Blue Shield of North Carolina (BCBSNC) covers Saxenda (liraglutide 3.0 mg) for weight loss, including prior authorization criteria, copay estimates, step therapy requirements, and how to appeal a denial.
Read clinical reviewFind out if BCBSNC covers Wegovy (semaglutide 2.4 mg) for weight loss, including prior authorization criteria, step therapy requirements, copay estimates, and appeal options.
Read clinical reviewGLP-1 receptor agonists like semaglutide and tirzepatide produce 15-25% body weight loss, far exceeding older obesity drugs. Learn the mechanisms, trial data, and safety profiles that set these medications apart.
Read clinical reviewLearn how to verify FDA approval for medications and legitimacy of pharmacies using official databases, NABP accreditation, and state licensing boards.
Read clinical reviewMounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that produces greater weight loss and A1C reduction than single-target GLP-1 drugs like semaglutide and liraglutide. Learn the mechanism, trial data, dosing, and side effects.
Read clinical reviewGLP-1 receptor agonists such as semaglutide affect dopamine reward circuits in the brain, reducing impulsive behaviors around food, alcohol, and other compulsive habits. Here is what the science shows.
Read clinical reviewMounjaro (tirzepatide) costs $1,023, $1,462 per month without insurance. Learn about list prices by dose, savings programs, compounded alternatives, and ways to reduce out-of-pocket spending.
Read clinical reviewMicrodosing GLP-1 receptor agonists like semaglutide and tirzepatide has gained social media traction, but clinical trial data tells a more complicated story. Here is what physicians and the research say about sub-therapeutic GLP-1 dosing.
Read clinical reviewTirzepatide (Mounjaro) side effects range from common GI symptoms like nausea and diarrhea to rare but serious risks including pancreatitis and thyroid tumors. Learn frequencies, timelines, and management strategies backed by trial data.
Read clinical reviewPeptides are short chains of amino acids that regulate hormones, metabolism, bone density, and more. This evidence-based guide explains how peptides work in women's health, which ones are FDA-approved, and what the research actually shows.
Read clinical reviewGLP-1 is a gut hormone that controls appetite and blood sugar. Learn how GLP-1 receptor agonist medications like semaglutide and tirzepatide produce significant weight loss, their mechanisms, side effects, and clinical evidence.
Read clinical reviewSaxenda (liraglutide 3.0 mg) is an FDA-approved GLP-1 receptor agonist for chronic weight management. Learn about dosing, clinical trial results, side effects, cost, and how it compares to semaglutide.
Read clinical reviewCalibrate prescribes Wegovy (semaglutide 2.4 mg) as part of a metabolic health program combining GLP-1 therapy with lifestyle coaching. Learn the clinical evidence behind this approach.
Read clinical review